BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15532987)

  • 1. Pneumococcal conjugate vaccines--a European perspective.
    Reinert RR
    Int J Med Microbiol; 2004 Oct; 294(5):277-94. PubMed ID: 15532987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
    Weil-Olivier C; Gaillat J
    Vaccine; 2014 Apr; 32(18):2022-6. PubMed ID: 24565755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of 7-valent pneumococcal conjugate vaccine.
    Ghaffar F
    Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
    von Kries R; Siedler A; Schmitt HJ; Reinert RR
    Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal vaccine development.
    Poolman JT
    Expert Rev Vaccines; 2004 Oct; 3(5):597-604. PubMed ID: 15485339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pneumococcal conjugate vaccine.
    Jacobson RM; Poland GA
    Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.
    Gaillat J
    Med Mal Infect; 2013 Jun; 43(6):215-21. PubMed ID: 23769155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation with a pneumococcal 7-valent conjugate vaccine.
    Dagan R
    Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.